Sanofi Q1 2015 Results - Interview With CFO Jérôme Contamine

Thursday, April 30, 2015

PARIS, April 30, 2015 /PRNewswire/ --

Sanofi, a global and diversified healthcare leader, reports results for the first quarter of 2015. Jérôme Contamine, Chief Financial Officer of Sanofi, comments on the Group's Q1 results and guidance for the rest of the year.

Watch video interview and read transcript:

Topics covered in the interview include: 

- Q1 2015 results

- Guidance for 2015

- Recent launches

- Diabetes

- Genzyme

- Animal Health and Consumer Healthcare

- Vaccines

- R&D pipeline

- Emerging Markets

About Sanofi 

Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and Genzyme. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).

Company website: